Добірка наукової літератури з теми "Dyscrasite"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Dyscrasite".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Dyscrasite"
Osadchii, E., D. Boström, S. Lunin, and E. Rosén. "Thermodynamic properties of dyscrasite (Ag 3 Sb) at isostatic pressures 4000-8000 bar." Physics and Chemistry of Minerals 25, no. 4 (March 19, 1998): 288–91. http://dx.doi.org/10.1007/s002690050116.
Повний текст джерелаKalinin, Arkadii A., Yevgeny E. Savchenko, and Ekaterina A. Selivanova. "Mustard Gold in the Oleninskoe Gold Deposit, Kolmozero–Voronya Greenstone Belt, Kola Peninsula, Russia." Minerals 9, no. 12 (December 13, 2019): 786. http://dx.doi.org/10.3390/min9120786.
Повний текст джерелаZachariáš, Jiří, and Matěj Němec. "Gold to aurostibite transformation and formation of Au-Ag-Sb phases: the Krásná Hora deposit, Czech Republic." Mineralogical Magazine 81, no. 4 (August 2017): 987–99. http://dx.doi.org/10.1180/minmag.2016.080.145.
Повний текст джерелаHartshorn, Edward A., Gary M. Levin, and C. Lindsay DeVane. "A Review of Cyclic Antidepressant-Induced Blood Dyscrasias." Annals of Pharmacotherapy 26, no. 3 (March 1992): 378–83. http://dx.doi.org/10.1177/106002809202600313.
Повний текст джерелаLatif, Zahid, Faraz Jabbar, and Brendan D. Kelly. "Clozapine and blood dyscrasia." Psychiatrist 35, no. 1 (January 2011): 27–29. http://dx.doi.org/10.1192/pb.bp.109.026054.
Повний текст джерелаSutherland, Rory A., and Richard I. Crawford. "Scalp biopsy identifies systemic amyloidosis presenting as isolated telogen effluvium: A case report." SAGE Open Medical Case Reports 7 (January 2019): 2050313X1984778. http://dx.doi.org/10.1177/2050313x19847783.
Повний текст джерелаDunk, Louisa R., Linda J. Annan, and Christopher D. Andrews. "Rechallenge with clozapine following leucopenia or neutropenia during previous therapy." British Journal of Psychiatry 188, no. 3 (March 2006): 255–63. http://dx.doi.org/10.1192/bjp.188.3.255.
Повний текст джерелаHarris, Donald C., Andrew C. Roberts, J. H. Gilles Laflamme, and Chris J. Stanley. "Criddleite, TlAg2Au3Sb10S10, a New Gold-Bearing Mineral from Hemlo, Ontario, Canada." Mineralogical Magazine 52, no. 368 (December 1988): 691–97. http://dx.doi.org/10.1180/minmag.1988.052.368.13.
Повний текст джерелаMunshi, Tariq, Farooq Naeem, Mohammed Ayub, Saeed Farooq, Davit Khachatryan, Selim Asmer, Peter Wang, et al. "The haematological side effects of clozapine: literature review and meta-analysis." BJPsych Open 7, S1 (June 2021): S274. http://dx.doi.org/10.1192/bjo.2021.729.
Повний текст джерелаMichaeli, J., R. Niesvizky, D. Siegel, M. Ladanyi, PH Lieberman, and DA Filippa. "Proteinaceous (angiocentric sclerosing) lymphadenopathy: a polyclonal systemic, nonamyloid deposition disorder." Blood 86, no. 3 (August 1, 1995): 1159–62. http://dx.doi.org/10.1182/blood.v86.3.1159.1159.
Повний текст джерелаДисертації з теми "Dyscrasite"
Ali, H. S. "Drug induced blood dyscrasias : Aminoglutethimide and related compounds." Thesis, Cardiff University, 1987. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.377874.
Повний текст джерелаLimpas, Yvon. "Le POEMS syndrome : entité particulière au sein des dyscrasies plasmocytaires." Bordeaux 2, 1989. http://www.theses.fr/1989BOR25325.
Повний текст джерелаPaletta, Dominique Raoux. "Syndrome de Crow-Fukase : à propos d'une observation et revue de la littérature." Montpellier 1, 1988. http://www.theses.fr/1988MON11235.
Повний текст джерелаSoubrier, Martin. "Le Syndrome POEMS." Clermont-Ferrand 1, 2003. http://www.theses.fr/2003CLF1MM11.
Повний текст джерелаGutknecht-Dignat, Sandrine. "Le syndrome d'hyperperméabilité capillaire idiopathique : à propos d'un cas." Montpellier 1, 1998. http://www.theses.fr/1998MON11040.
Повний текст джерелаCARLISI, Melania. "EVALUATION AND POTENTIAL ROLE OF BONE MARROW TISSUE-RESIDENT MEMORY T-CELLS IN PATIENTS WITH PLASMA CELL DYSCRASIAS." Doctoral thesis, Università degli Studi di Palermo, 2020. http://hdl.handle.net/10447/400371.
Повний текст джерелаMILANI, PAOLO. "The use of mass spectrometry for the diagnosis of plasma cell dyscrasias: focus on light chain (AL) amyloidosis patterns." Doctoral thesis, Università degli studi di Pavia, 2019. http://hdl.handle.net/11571/1285988.
Повний текст джерелаKiran, Aramanda Shanmukha. "Exotic eutectic microstructures." Thesis, 2021. https://etd.iisc.ac.in/handle/2005/5476.
Повний текст джерелаHavyarimana, Sandra. "Evaluation of prognostic markers in plasma cell dyscrasias." Thesis, 2017. https://hdl.handle.net/10539/24917.
Повний текст джерелаIntroduction: Plasma cell dyscrasias (PCDs) are a heterogeneous group of diseases in which there is expansion of clonal plasma cells which may produce monoclonal immunoglobulins. CD200 is a membrane glycoprotein of the type I immunoglobulin superfamily transmembrane glycoprotein. It is postulated that CD200 is expressed by the plasma cells in a significant number of cases of multiple myeloma (MM), but normal plasma cells do not express it. It may thus assist in confirming clonality of plasma cells in PCDs. Aims: To evaluate CD200 expression as a potential diagnostic and prognostic marker in plasma cell dyscrasias and to compare the results with other known prognostic factors. Methods: CD200 expression was evaluated by immunophenotypic analysis on normal, reactive and clonal plasma cells and expressed as a mean fluorescent intensity (MFI) value. Cut-off for positive CD200 was established. A negative population was established using different methodologies to exclude reactive plasma cells. CD200 was then compared with diagnostic and prognostic markers currently in use in our laboratory. Results: An MFI of ≥ 30 was the cut-off for CD200 positivity. CD200 was expressed by 76.5% of PCDs cases. CD200 did not predict anaemia, hypercalcaemia or renal dysfuction which are biochemical criteria for the diagnosis of multiple myeloma. CD200 expression did not correlate with traditional prognostic markers such as beta 2 microglobulin (β2M), lactate dehydrogenase (LDH) or genetic abnormalities (by fluorescence in situ hybridization analysis). Cases with plasma cell CD200 expression had a higher monoclonal band level compared to those without CD200 expression. Conclusion: CD200 is a useful tool to evaluate plasma cell clonality; however in our settings where there is a high prevalence of infectious diseases, particularly HIV infection, CD200 might yield false positive results most likely because of small oligoclones of reactive plasma cells. CD200 as a prognostic tool in PCDs could not be confirmed in this small study.
LG2018
Phipps, Jonathan E. "Toward Personalized Medicine: The potential role of RNA interference in Plasma Cell Dyscrasia." 2011. http://trace.tennessee.edu/utk_graddiss/1217.
Повний текст джерелаКниги з теми "Dyscrasite"
Roccaro, Aldo M., and Irene M. Ghobrial, eds. Plasma Cell Dyscrasias. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5.
Повний текст джерелаKelly, John J., Robert A. Kyle, and Norman Latov. Polyneuropathies Associated with Plasma Cell Dyscrasias. Boston, MA: Springer US, 1987. http://dx.doi.org/10.1007/978-1-4613-2065-4.
Повний текст джерелаMinetti, Luigi, Giuseppe D’Amico, and Claudio Ponticelli, eds. The Kidney in Plasma Cell Dyscrasias. Dordrecht: Springer Netherlands, 1988. http://dx.doi.org/10.1007/978-94-009-1315-8.
Повний текст джерела1928-, Kyle Robert A., and Latov Norman, eds. Polyneuropathies associated with plasma cell dyscrasias. Boston: Nijhoff, 1987.
Знайти повний текст джерелаL, Minetti, D'Amico G. 1929-, and Ponticelli C, eds. The Kidney in plasma cell dyscrasias. Dordrecht: Kluwer Academic Publishers, 1988.
Знайти повний текст джерелаZimmerman, Todd M., and Shaji K. Kumar, eds. Biology and Management of Unusual Plasma Cell Dyscrasias. New York, NY: Springer New York, 2017. http://dx.doi.org/10.1007/978-1-4419-6848-7.
Повний текст джерелаW, Pruzanski, and Keystone E. C, eds. Paraproteins in disease: Investigation of plasma cell dyscrasia. Edinburgh: Churchill Livingstone, 1985.
Знайти повний текст джерелаW, Pruzanski, and Keystone E. C, eds. Paraproteins in desease: Investigation of plasma cell dyscrasia. Edinburgh: Churchill Livingstone, 1985.
Знайти повний текст джерелаGhobrial, Irene M., and Aldo M. Roccaro. Plasma Cell Dyscrasias. Springer, 2018.
Знайти повний текст джерелаPlasma Cell Dyscrasias. Springer, 2016.
Знайти повний текст джерелаЧастини книг з теми "Dyscrasite"
Castroviejo, Ricardo. "Dyscrasite (dy, dyscrasite, stibiotriargentite)." In A Practical Guide to Ore Microscopy—Volume 1, 265–68. Cham: Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-12654-3_44.
Повний текст джерелаSpeer, Tod W., Christin A. Knowlton, Michelle Kolton Mackay, Charlie Ma, Lu Wang, Larry C. Daugherty, Brandon J. Fisher, et al. "Dyscrasias." In Encyclopedia of Radiation Oncology, 168. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-540-85516-3_596.
Повний текст джерелаMateos, María-Victoria, and Ola Landgren. "MGUS and Smoldering Multiple Myeloma: Diagnosis and Epidemiology." In Plasma Cell Dyscrasias, 3–12. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_1.
Повний текст джерелаNeri, Paola, Nizar J. Bahlis, Claudia Paba-Prada, and Paul Richardson. "Treatment of Relapsed/Refractory Multiple Myeloma." In Plasma Cell Dyscrasias, 169–94. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_10.
Повний текст джерелаLonial, Sagar. "Treatment of MM: Upcoming Novel Therapies." In Plasma Cell Dyscrasias, 195–205. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_11.
Повний текст джерелаLee, Susan J., and Ivan Borrello. "Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma." In Plasma Cell Dyscrasias, 207–25. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_12.
Повний текст джерелаJethava, Yogesh S., and Frits van Rhee. "Transplantation for Multiple Myeloma." In Plasma Cell Dyscrasias, 227–50. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_13.
Повний текст джерелаEda, Homare, Loredana Santo, G. David Roodman, and Noopur Raje. "Bone Disease in Multiple Myeloma." In Plasma Cell Dyscrasias, 251–70. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_14.
Повний текст джерелаDispenzieri, Angela, and Giampaolo Merlini. "Immunoglobulin Light Chain Systemic Amyloidosis." In Plasma Cell Dyscrasias, 273–318. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_15.
Повний текст джерелаKapoor, Prashant, Stephen M. Ansell, and Esteban Braggio. "Waldenstrom Macroglobulinemia: Genomic Aberrations and Treatment." In Plasma Cell Dyscrasias, 321–61. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-40320-5_16.
Повний текст джерела